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Weaning is a challenging stage of pig farming. Animals undergo environmental, social and dietary
changes leading to weaning stress syndrome. In order to compensate for the detrimental effects of
weaning stress, antibiotics and natural extracts are used as feed additives, sometimes without fully
understanding the interactions between them or even with low concentrations of mycotoxins that are
frequently present in feed. The aim of this study was to evaluate the effect of fosfomycin (FOS), Cynara
scolymus extract (CSE), deoxynivalenol (DON) and their combined administration on intestinal health of
weaned piglets. The experiment was designed as a 2  2  2 factorial arrangement with 3 factors (FOS,
CSE and DON treatments), 2 levels each (presence and absence) and 3 repeats. Weaned piglets (n ¼ 24)
were randomly divided in groups to receive the different treatments, namely DON administered in diet
(50 mg/kg BW), FOS administered into the drinking water (30 mg/kg BW), CSE administered in diet
(15 mg/kg BW) and all their combinations. After 15 d, the animals were euthanized and gastrointestinal
tract samples were immediately taken to evaluate gastrointestinal pH, Enterobacteriaceae to lactic acid
bacteria (E:L) ratio, volatile fatty acid (VFA) concentrations, disaccharidase (lactase, sucrase and maltase)
activity, histology (intestinal absorptive area [IAA] and goblet cells count) and mucus ability to adhere
pathogenic Escherichia coli. From our results, FOS and CSE treatments, individually or combined, pro-
duced a lower E:L ratio, an enhanced production of butyrate, increased disaccharidase activity (partic-
ularly maltase), and a greater IAA and goblet cells count along with an increase in pathogenic bacteria
adherence to intestinal mucus. Deoxynivalenol did not show interactions with the other factors and its
administration produced decreases on VFA, disaccharidase activity and goblet cells count. In conclusion,
weaning piglets receiving diets containing FOS, CSE or both exhibited evident beneficial intestinal effects
compared to animals receiving diets free from these compounds. On the contrary, the presence of DON at
sub-toxic concentrations produced detrimental effects on intestinal health. The knowledge of thertínez).
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their potential productive consequences.
© 2019, Chinese Association of Animal Science and Veterinary Medicine. Production and hosting
by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Weaning is considered one of the most critical periods of pig
production because of its high negative impact on health and
productive performance of piglets, mainly in the first post-weaning
days. During this period, the animals are exposed to physiological,
immunological, microbiological, social, environmental and nutri-
tional factors that lead to post-weaning stress (Hampson and
Kidder, 1986; Lalles et al., 2007; Heo et al., 2013). In order to
overcome this situation, the prophylactic use of antibiotics has
become a common practice. Fosfomycin (cis 1-2 epoxy propyl
phosphonic acid, FOS) is a broad spectrum bactericide antibiotic,
widely used in pig farms in Central and South America, South Africa
and Southeast Asia. At weaning, FOS is indicated for the treatment
of several bacterial infections (Haemophilus parasuis, Streptococcus
suis, Pasteurella multocida, Bordetella bronchiseptica, Staphylococcus
hyicus, Escherichia coli, etc.) associated to stress (Martineau and
Morvan, 2010).
On the other hand, vegetable extracts, particularly Cynara sco-
lymus extract (CSE), have long been used in different species for
their hepatoprotective and digestive roles. In animal production,
these compounds are used as feed additives to improve zootech-
nical parameters as body weight gain, feed intake and feed con-
version ratio (Abbasi and Samadi, 2014; Martínez and Uculmana,
2016; Saeed et al., 2017). In addition, they have shown further
beneficial consequences on intestine and liver functions. C. scoly-
mus extract is obtained from the leaves of the plant and contains
caffeolquinic acid derivatives which are known for their choleretic
e cholagogue effect in different species (Speroni et al., 2003;
Martínez and Uculmana, 2016), including pigs (Martínez et al.,
2018). As a consequence, increased bile concentrations at small
intestine level enhance fat and lipophilic vitamins absorption.
Furthermore, entero-protective, trophic, antitoxic and antimicro-
bial effects are ascribable to bile action (Bertok, 2004; Inagaki et al.,
2006; Mikov et al., 2006; Chiang, 2009). These functions provide
important benefits during stressful periods like weaning.
Among weaning stress factors, the presence of anti-nutritional
compounds in feed, such as mycotoxins, negatively influence pro-
ductive performance of animals. Deoxynivalenol (DON) is a myco-
toxin produced by Fusarium species, being pigs the most
susceptible species to its toxic effects (Rotter, 1996; Piotrowska
et al., 2014). Formerly DON was also called vomitoxin, referring to
its emetic effect (Vesonder et al., 1973; Eriksen and Pettersson,
2004). Other clinical signs of intoxication with DON include
reduction in feed intake and complete feed refusal, immunosup-
pression, haemorrhage and eventually, circulatory shock (Lawlor
and Lynch, 2001; Pestka, 2007; Alizadeh et al., 2015). However,
there is little information on the possible subclinical effects asso-
ciated to the ingestion of feed contaminated with low DON con-
centrations, which is highly likely to occur (Eriksen and Pettersson,
2004; Roige et al., 2009; Wache et al., 2009).
In intensive pig production, in innumerable situations, but
mostly during weaning, antibiotics, natural extracts and low con-
centrations of mycotoxins coexist in the animals' diet, and conse-
quently in the gut, regardless the potential interactions among
them. We hypothesize that the presence of these compounds,
individually or combined, influence intestinal health. The aim ofthis study was to evaluate the effect of FOS, CSE, DON and their
combined administration on the intestinal health of weaned
piglets.
2. Materials and methods
The study was carried out according to guidelines of the Animal
Welfare Committee of the Faculty of Veterinary Sciences UNCPBA,
Argentina, for animal handling and experimentation.
2.1. Experimental design
The experiment was designed as a 2  2  2 factorial treatment
arrangementwith 3 factors (FOS, CSE and DON treatments), 2 levels
each: presence and absence and 3 repeats.
Twenty-fourweaned piglets were randomly distributed in order
to receive, daily, one of the following combinations of factors: DON
(50 mg/kg BW); FOS (30 mg/kg BW); CSE (15 mg/kg BW); DON
(50 mg/kg BW) þ FOS (30 mg/kg BW); DON (50 mg/kg BW) þ CSE
(15 mg/kg BW); CSE (15 mg/kg BW) þ FOS (30 mg/kg BW); DON
(50 mg/kg BW) þ CSE (15 mg/kg BW) þ FOS (30 mg/kg BW) and a
balanced diet without FOS, CSE or DON. Thus, each level of each
factor was assigned to 12 piglets.
Hereunder, animals receiving any of the treatments will be
referred to as FOS, CSE or DON treated animals and as FOS, CSE or
DON free animals in the absence of the corresponding factors.
2.2. Animals
Twenty-four, healthy, 21-d-old, just weaned piglets
(6.26 ± 0.4 kg BW) of the same genetic line from a commercial farm
were used. Piglets receiving each combination of factors were
housed in pens inside an environmentally controlled barn
(22 ± 5 C; 12:12 lightedark cycles; relative humidity 45% to 65%),
given free access to feed (commercial feed, Perfecto Transicion,
Biofarma S.A.: 3,325 kcal/kg of metabolizable energy; Table 1) and
water, and checked daily for clinical symptoms of DON intoxication.
Feed and water consumption were monitored in order to assure
that total doses of each treatment were taken. After 15 d of treat-
ment, piglets of each group were euthanized for sampling of the
gastrointestinal tract.
2.3. Antibiotic, natural extract and mycotoxin
Fosfomycin (FOS): calcium fosfomycin (Fosbac) was provided by
Bedson S.A. laboratory (Pilar, Buenos Aires, Argentina). The anti-
biotic was dissolved in drinking water. Water consumption was
measured by a water flow meter installed at the entrance pipeline
of the weaning room 2 d before the beginning of the trial. Medi-
cated water was prepared daily at 08:00, considering water con-
sumption and mean piglets weight in order to obtain the adequate
dosage. A FOS dose of 30 mg/kg per d was used as this is the rec-
ommended prescription for the treatment of systemic infections at
weaning (Perez et al., 2012; Soraci et al., 2014).
C. scolymus extract (CSE): this natural extract (Bedgen40) was
provided by Bedson S.A. laboratory (Pilar, Buenos Aires, Argentina).
Three hundred grams of CSE were uniformly mixed with 1 t of feed.
Table 1
Ingredients and analysed composition of the basal diet (as-fed basis, %).
Item Content
Ingredients1
Corn 66.67
Soybean pellet 23.33
Soybean expeller 6.67
Premix2 3.33
Analysed composition
Metabolizable energy, kcal/kg 3,325
Minimum protein content 20.00
Maximum humidity 12.00
Maximum mineral content 3.8
Ether extract 5.00
Maximum crude fibre 2.00
Minimum calcium content 8.00
Minimum total phosphorous content 4.00
Total lysine 1.62
Total methionine 0.437
Total tryptophan 0.275
Total threonine 1.085
Lactose 12.00
Sodium 0.28
Chloride 0.25
Average available phosphorous 3.80
1 Ingredients contents meet nutritional requirements of weaning pigs (Rostagno
et al., 2017).
2 Premix includes vitamins, minerals and other protein and carbohidrates
sources.
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based on studies in which choleretic and cholagogue effects of CSE
in pigs have been demonstrated (Martínez et al., 2018).
Deoxynivalenol (DON): the mycotoxin was produced in our
laboratory by growing Fusarium graminearum NRRL 28063 in corn
at 25 C for 25 d. For DON quantification, samples of ground corn
were extracted twice with water or acetonitrile and then with
hexane by liquideliquid extraction. Extracts were passed through
columns (DONPREP, Glascow, Scotland) and evaporated to dryness
at 40 C. The dry extract was reconstituted with MilliQ water and
filtered through 0.22 mm nylon membranes before injection into
HPLC UV/VIS for quantification. A Gilson HPLC system equipped
with a Gilson 151 UVeVis detector and Gilson 712 software was
used for data analysis (Gilson, Inc., Middleton, USA). The column
(250 mm  3.00 mm, 4 mm; Sinergy Hydro-RP C18, Phenomenex,
Torrance, USA) was maintained at 35 C. The mobile phase was a
water-acetonitrile mixture (90%, wt/wt) at 0.5 mL/min flow rate.
Deoxynivalenol was detected at 222 nm and its retention time was
8.7 min.
Feed was previously analyzed in order to confirm the absence of
mycotoxins using the method described by Roige et al. (2009). Al-
iquots of ground contaminated corn were uniformly mixed with
feed in order to obtain 1 mg DON/kg. This is considered a low level
of this mycotoxin, which is likely to occur in feed, but for which no
clinical signs have been observed other than reduced feed intake
(Eriksen and Pettersson, 2004; Yeong-hsiang et al., 2006; Chaytor
et al., 2011).2.4. Gastrointestinal tract study
2.4.1. pH determination
As soon as each sample was obtained, pH was measured with a
pH meter (UP-25, Denver Instrument Company, Denver, Colorado)
in the caudal portion of the stomach, ileum (15 cm proximal to
ileocecal valve), caecum and colon (20 cm distal from caecum). The
pH meter was calibrated in the range of pH 4 to 7 strictly following
manufacturer's instructions.2.4.2. Enterobacteriaceae to lactic acid bacteria (E:L) ratio
The intestinal contents from caecum and colon (20 cm distal
from caecum) were collected and kept at 4 C until arrival to the
laboratory, within a maximum period of 4 h. One gram of sample
was immediately diluted in 9 mL of peptone water and homoge-
nized by continuous agitation. Bacteria cultures were performed by
plating serial 10-fold dilutions (in 1% peptonewater) ontoMRS agar
(Britania S.A.) for lactic acid bacteria (LAB), representative of
beneficial bacteria in pigs, and onto Mac Conkey agar (Britania S.A.)
for Enterobacteriaceae, representative of commensal Gram negative
bacteria (Macconkey, 1900; De Man et al., 1960; White et al., 2002;
Mikkelsen and Jensen, 2004). Colonies were counted, log trans-
formed and expressed as log10 of colony forming units per gram of
digesta (log10 CFU/g).
2.4.3. Volatile fatty acids (VFA)
One gram of caecal contents was immediately diluted with
phosphoric acid (4:1, wt./wt.) for preservation and kept at 70 C
until analyzed. Concentrations of VFA were determined using gas
liquid chromatography according to the method described by
Jouany (1982). A Shimadzu chromatograph (Model GCe17A, Kyoto,
Japan) with a 19091N-133 Innowax 30M column (Agilent, Santa
Clara, CA, USA) was used. A mixture of 10 mmol/L Supelco VFA (C2
to C10) and 2-ethyl-butyric acid (Fluka) as internal standard were
used to build calibration curves.
2.4.4. Disaccharidases activity
Four portions of the small intestine (duodenum, proximal and
medium jejunum and ileum) were opened along the mesenteric
border and washed with saline solution to eliminate the mucus and
remaining intestinal contents. Themucosawas carefully scraped off
with a scalpel and 1 g of this material was weighed. Then, saline
solution (2 mL) was added and the intestinal mucosa was ground
with a dispersing instrument (Ultra-Turrax) and a Potter homoge-
nizer. Samples were then cold-centrifuged at 4 C and 4,825  g for
10 min. The supernatant represented the crude enzyme solution
and it was stored at 70 C until analysis. Protein concentration of
each homogenate was determined by Bradford method using
bovine serum albumin as standard (Bradford, 1976). The activity of
sucrase, lactase and maltase was determined by quantification of
released glucose, according to Dahlqvist method (Dahlqvist, 1964).
Briefly, the homogenate supernatants were diluted, added to an
equal volume of 0.1 mol/L sodium maleate buffer (pH 6.0) con-
taining 56 mmol/L lactose, sucrose or maltose, and incubated for
1 h at 37 C. Then, the mixtures were added to the glucose
oxidaseeperoxidase reagents (Sigma Chemical Company, USA)
containing O-dianisidine as chromogen. The absorbance was
measured using a spectrophotometer (Dupont, Sorvall In-
struments) at 450 nm. Disaccharidases activity was expressed as
U/mg protein. One U is defined as the amount of enzyme that hy-
drolyses 1 mmol of lactose, sucrose or maltose in 1 min under the
standard assay conditions.
2.4.5. Histological study
Samples of medium jejunum (1.5 m from stomach) and ileum
(20 cm proximal to ileocecal valve) were washed with saline so-
lution to remove intestinal contents, transversally cut and fixed in
Bouin solution (75% saturated picric acid, 20% formaldehyde and
5% acetic acid). After 24 h, the samples were embedded in paraffin
and stained with haematoxylin-eosin (H&E) and periodic acid-
Schiff (PAS).
The intestinal mucosa was examined under light microscope
and analyzed using the Image Analysis Software (ToupTek Toup-
View). The length and width of villi and width of crypts were
measured in H&E-stained sections. Fifty villi and 50 crypts were
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crypt widths were calculated. The mathematical model proposed
by Kisielinski et al. (2002) was used to estimate the intestinal
absorptive area (IAA) using the following equation:
IAA¼ðvillusW  villusLÞ þ ðvillusW=2þ cryptW=2Þ2
 ðvillusW=2Þ2
.
ðvillusW=2þ cryptW=2Þ2;
where, IAA¼ intestinal absorptive surface area, villusW¼ villi mean
width, villusL¼ villi mean length, and cryptW¼ crypts meanwidth.
Goblet cells in villi and crypts (expressed as goblet cells/100 villi
or crypts) were determined using PAS staining and mean values
were calculated (Buddle and Bolton, 1992; Burrin et al., 2001).
2.4.6. Adherence of bacteria to intestinal mucus
Ileum samples (15 cm proximal to ileocecal valve) were opened
along the mesenteric border. Mucus was carefully scraped off with
a scalpel (leaving intestinal mucosa intact), collected into sterile
tubes and kept at 70 C until analyzed. Adherence of bacteria to
mucus was assessed according to Bai et al. (2000). Briefly,100mg of
mucus were diluted with 1.5 mL of saline solution and centrifuged
(14,400  g, 10 min, 4 C) to remove cell debris and bacteria. The
supernatant was sterilized by filtration (13 mm  0.22 mm nylon
filter membranes) and the filtered solution was defined as the
original crude mucus that contained glycoproteins responsible for
bacteria adherence. A concentration of 103 CFU/mL of E. coli
O157:H7 was incubated with supernatant containing crude mucus
for 30 min, at 37 C under continuous agitation. Then the tubes
were centrifuged (14,400  g, 10 min, 4 C) and pellets (with
adhered and not adhered bacteria) were resuspended in 400 mL
saline solution and further centrifuged (400  g, 4 C, 2 min). Two
fractions were obtained, the pellet which contained adhered bac-
teria and the supernatant which contained not adhered bacteria.
Aliquots from pellet and supernatant were spread on Mac Conkey
Agar with Sorbitol (Britania S.A.) and incubated under aerobic
condition for 24 h at 37 C for colonies count. Results were
expressed as percentage of adhered bacteria to the intestinal
mucus.
2.5. Statistical analyses
The response variables (pH, intestinal bacteria, VFA, di-
saccharidases activity, IAA, goblet cells and percentage of adhered
bacteria to intestinal mucus) were analyzed by ANOVA by GLM
procedure of SASV9.3 (SAS Institute Inc., Cary, NC, USA). Differences
between treatments were declared significant when P < 0.05.
When statistically significant interactions were observed, contrasts
(using Tukey's test) were carried out to compare the different levels
of each treatment. Data are presented in tables as means and mean
standard error (SEM).
3. Results
3.1. pH
Effects of interactions among different factors on pH values were
not observed (P > 0.05).
Mean pH values obtained for each treatment are shown in
Table 2. No statistically significant differences were obtained be-
tween CSE or DON treated and CSE or DON free animals in the
gastrointestinal portions analyzed. Additionally, FOS treated ani-
mals showed no statistically significant effects in caudal portion of
stomach and ileum, but they showed a lower pH (P < 0.01) in
caecum and colon, (5.51 ± 0.26 and 6.21 ± 0.39, respectively),compared to FOS free animals (6.66 ± 0.32 and 7.25 ± 0.27,
respectively).3.2. Enterobacteriaceae, lactic acid bacteria and Enterobacteriaceae
to lactic acid bacteria (E:L) ratio
3.2.1. Lactic acid bacteria
Effects of interactions among different factors on LAB log10 CFU/g
values were not observed (P > 0.05).
Results did not show statistically significant differences be-
tween FOS, CSE or DON treated and FOS, CSE or DON free animals
(P > 0.05).3.2.2. Enterobacteriaceae
The co-administration of CSE and FOS at colon level resulted in a
reduction of Enterobacteriaceae log10 CFU/g and E:L ratio (P < 0.05)
being the outcome similar to that observed when the factors were
administered individually. At caecum level, an interaction was
found between CSE and FOS (P < 0.05) but the reduction in
Enterobacteriaceae log10 CFU/g and E:L ratio was less evident than
in colon. No further interactions were observed among factors.
No statistically significant differences were found for Entero-
bacteriaceae log10 CFU/g and E:L ratio between DON treated and
DON free animals.
Fosfomycin and CSE treated animals exhibited lower Entero-
bacteriaceae log10 CFU/g and lower E:L ratio, in caecum and colon,
than FOS and CSE free animals (P < 0.05) (regardless the presence of
DON). Results are shown in Table 3.3.3. Volatile fatty acids
Effects of interactions among different factors on VFA concen-
trations were not observed (P > 0.05).
C. scolymus extract and FOS treated animals showed numerically
higher concentrations of acetate, propionate, butyrate and total VFA
than CSE and FOS free animals (P > 0.05 except for butyrate con-
centrations in CSE treatment where P < 0.05). Deoxynivalenol
treated animals showed significantly lower acetate, propionate and
butyrate concentrations, and consequently lower total VFA con-
centrations than DON free animals (P < 0.05 for all acids). Results
are shown in Table 4.3.4. Disaccharidases activity
Effects of interactions among different factors on disaccharidase
activity were not observed (P > 0.05).
Disaccharidases activity mean values for each treatment are
shown in Table 5. It was found that maltase activity in all intestinal
portions from FOS treated animals was significantly higher than
that observed for FOS free animals (P < 0.05). Sucrase and lactase
activity also increased in jejunum and ileum of FOS treated animals,
though this effect was not statistically significant.
C. scolymus extract treated animals showed a higher maltase
activity in ileum compared to CSE free animals (P < 0.05). How-
ever, an effect on sucrase and lactase activity was not observed
(P > 0.05).
Deoxynivalenol treated animals showed lower disaccharidase
activity than DON free animals in all intestinal portions. P < 0.05
was observed for maltase activity in duodenum, proximal jejunum
and ileum, sucrase activity in medium jejunum and lactase activity
in duodenum and jejunum.
Table 2
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and deoxynivalenol (DON) on the gastrointestinal pH (n ¼ 12).
Item FOS, mg/kg BW P-value CSE, mg/kg BW P-value DON, mg/kg BW P-value
0 30 0 15 0 50
Stomach 3.50 ± 0.18 3.49 ± 0.27 0.9613 3.48 ± 0.15 3.51 ± 0.28 0.9458 3.64 ± 0.25 3.35 ± 0.19 0.4063
Ileum 7.24 ± 0.24 6.95 ± 0.37 0.5329 6.94 ± 0.32 7.24 ± 0.31 0.5283 6.93 ± 0.34 7.25 ± 0.29 0.4947
Caecum 6.66 ± 0.32 5.51 ± 0.26 0.0123 6.18 ± 0.34 5.99 ± 0.34 0.6372 5.81 ± 0.29 6.36 ± 0.37 0.1962
Colon 7.25 ± 0.27 6.21 ± 0.39 0.0376 6.90 ± 0.35 6.56 ± 0.38 0.4816 6.33 ± 0.37 7.13 ± 0.34 0.1124
Table 3
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and their combination on the Enterobacteriaceae and Enterobacteriaceae to lactic acid bacteria (E:L) ratio (n ¼ 6).
Item 0 FOS 30 mg/kg BW FOS P-value
0 CSE 15 mg/kg BW CSE 0 CSE 15 mg/kg BW CSE FOS  CSE
Enterobacteriaceae, log10 CFU/g
Caecum 5.85 ± 0.60a 3.01 ± 0.37b 2.42 ± 0.84b 4.35 ± 0.62ab 0.0012
Colon 6.49 ± 0.44a 2.87 ± 0.41b 2.53 ± 0.86b 3.39 ± 0.48b 0.001
E:L ratio
Caecum 0.79 ± 0.07a 0.43 ± 0.05b 0.37 ± 0.13b 0.60 ± 0.09ab 0.0056
Colon 0.85 ± 0.04a 0.41 ± 0.07b 0.38 ± 0.13b 0.44 ± 0.07b 0.0114
FOS  CSE ¼ combination of FOS and CSE.
a, b Within a row, mean values with different superscript letter differ significantly (P < 0.05).
Table 4
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and deoxynivalenol (DON) on volatile fatty acid (VFA) concentrations (mmol/L) in the caecum of weaned piglets
(n ¼ 12).
Item FOS, mg/kg BW P-value CSE, mg/kg BW P-value DON, mg/kg BW P-value
0 30 0 15 0 50
Acetate 47.36 ± 6.11 60.35 ± 7.31 0.1363 46.51 ± 6.29 61.20 ± 7.00 0.0945 63.58 ± 7.78 44.12 ± 4.55 0.0307
Propionate 13.27 ± 1.71 16.44 ± 1.60 0.0698 13.19 ± 1.74 16.51 ± 1.56 0.0588 18.56 ± 1.41 11.15 ± 1.21 0.0002
Butyrate 5.44 ± 0.80 6.78 ± 1.03 0.1493 5.17 ± 0.85 7.05 ± 0.96 0.0481 8.24 ± 0.91 3.98 ± 0.39 0.0001
Total VFA 68.47 ± 8.72 85.53 ± 9.69 0.1291 67.39 ± 8.96 86.61 ± 9.29 0.0897 93.20 ± 9.93 60.81 ± 6.08 0.0070
Table 5
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and deoxynivalenol (DON) on disaccharidases activity (U/mg protein; n ¼ 12).
Item FOS, mg/kg BW P-value CSE, mg/kgBW P-value DON, mg/kg BW P-value
0 30 0 15 0 50
Duodenum
Maltase 1,440.60 ± 183.45 2,422.91 ± 338.39 0.0012 1,951.87 ± 350.73 1,911.64 ± 262.55 0.8743 2,462.37 ± 339.66 1,401.15 ± 159.56 0.0006
Sucrase 39.82 ± 16.30 36.86 ± 8.85 0.8841 41.32 ± 15.17 35.36 ± 10.62 0.7688 41.69 ± 10.17 34.99 ± 15.46 0.7414
Lactase 88.42 ± 31.15 88.19 ± 27.68 0.9951 72.60 ± 18.06 104.00 ± 36.96 0.4024 141.09 ± 33.98 35.51 ± 8.68 0.0106
Proximal jejunum
Maltase 2,001.63 ± 249.50 3,419.02 ± 456.61 0.0043 2,727.34 ± 465.01 2,693.32 ± 381.81 0.9374 3,420.65 ± 461.72 2,000.01 ± 239.05 0.0042
Sucrase 96.48 ± 31.11 133.11 ± 51.55 0.5497 133.87 ± 28.64 95.72 ± 52.92 0.5334 145.62 ± 53.67 83.97 ± 25.16 0.3190
Lactase 171.45 ± 52.60 257.84 ± 91.37 0.3935 214.62 ± 55.72 214.67 ± 91.38 0.9996 324.52 ± 93.05 104.78 ± 24.51 0.0383
Medium jejunum
Maltase 2,795.56 ± 306.05 4,333.48 ± 493.03 0.0097 3,854.78 ± 549.21 3,274.27 ± 356.80 0.2844 4,038.04 ± 432.94 3,091.00 ± 464.81 0.0896
Sucrase 174.12 ± 51.79 284.39 ± 66.33 0.1369 259.65 ± 63.40 198.85 ± 58.71 0.4006 319.49 ± 69.41 139.02 ± 36.55 0.0208
Lactase 212.66 ± 66.42 342.47 ± 79.00 0.1627 316.65 ± 72.98 238.48 ± 76.25 0.3931 407.83 ± 80.99 147.30 ± 42.11 0.0087
Ileum
Maltase 1,071.56 ± 138.01 1,464.9 ± 265.51 0.0456 947.73 ± 122.61 1,588.72 ± 250.73 0.0028 1,623.23 ± 259.01 913.22 ± 81.07 0.0012
Sucrase 15.27 ± 9.86 59.01 ± 45.49 0.3441 15.72 ± 9.81 15.33 ± 5.18 0.3539 57.68 ± 45.56 16.59 ± 10.07 0.3733
Lactase 11.24 ± 3.64 18.26 ± 5.51 0.1875 14.16 ± 4.36 58.55 ± 45.54 0.8208 15.69 ± 4.86 13.80 ± 4.70 0.7159
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3.5.1. Intestinal absorptive area
At medium jejunum and ileum, interactions between DON and
the other factors were not observed (P > 0.05). Deoxynivalenol
treated animals showed no statistically significant differences
compared to DON free animals.
At medium jejunum, the co-administration of CSE and FOS
resulted in a lower effect than both individual factors (P < 0.05). In
this way, FOS and CSE treated animals exhibited higher IAA
compared to FOS and CSE free animals (P < 0.05).At ileum level, effects of interactions between FOS and CSE on
IAAwere not observed (P > 0.05). Values were higher in CSE treated
animals than in CSE free animals (P < 0.05). No differences were
observed between FOS treated, FOS free animals (P > 0.05). Results
are shown in Table 6.
3.5.2. Goblet cells
Interactions among different factors on goblet cells counts were
not significant (P > 0.05).
Fosfomycin and CSE treated animals exhibited higher goblet
cells counts in crypts than FOS and CSE free animals (P < 0.05) in
G. Martínez et al. / Animal Nutrition 5 (2019) 386e395 391both intestinal portions, while no significant differences were
found in villi (P > 0.05). For DON treated animals, lower goblet cells
counts were obtained in villi of both intestinal portions (P < 0.05)
but no effect was observed at crypts level. Results are shown in
Table 7.
3.6. Adherence of bacteria to the intestinal mucus
The co-administration of CSE and FOS resulted in an increase of
adherence of E. coli to intestinal mucus (P < 0.05) being the
outcome similar to that observed when the factors were adminis-
tered individually (81.61%). Interactions between DON and the
other factors were not observed (P > 0.05).
Adhesion increased from 44.57% in FOS and CSE free animals to
83.67% and 73.14% for FOS and CSE treated animals, respectively
(P < 0.05). Results are shown in Table 8. No significant differences in
E. coli adhesion to mucus were observed between DON treated
(67.53%) and DON free animals (73.96%) (P > 0.05).
4. Discussion
Weaning is the stage of pig farming where the greatest use of
natural extracts andsynthetic compoundsoccurs.When incorporated
as feed additives, focus is made on their individual benefits without
considering, sometimeswithoutknowing, theirmechanismsofaction
andpossible interactionsamongdifferentadditivesorevenwithother
anti-nutritional factors that may be present in feed. Fosfomycin, CSE
andDONare commonly found in theweaningdiet. Thesecompounds,
individually or combined, may impact on important morphological,
histological and microbiota modifications produced during weaning,
affecting the animals' productive outcome.
4.1. Bacteria, volatile fatty acids and pH
Lactic acid bacteria in the gastrointestinal tract were not influ-
enced by any of the treatments in the present study. Accordingly,
natural resistance of LAB strains to antibiotics and bile salts,
increased by feed consumption, has been largely demonstrated
(Piotrowska et al., 2014; Dowarah et al., 2017; Liao and Nyachoti,
2017).
Deoxynivalenol showed no effect on Enterobacteriaceae pop-
ulations and pH values were conserved in all gastrointestinal tract
portions. The influence of mycotoxins on intestinal microbiota of
pigs has been poorly investigated. Available data relies mainly on
the ability of bacteria to detoxify mycotoxins (Eriksen et al., 2002;
Niderkorn et al., 2006; Young et al., 2007; Wache et al., 2009). In
agreement with our results, a study conducted by Wache et al.
(2009) showed that cultivable bacteria diversity in fecal samples
was conserved in animals that consumed feed that was naturally
contaminated with DON (2.8 mg/kg). It is likely that gut bacteria
possess resistance mechanisms against this mycotoxin. In fact,
in vitro studies identified intestinal bacterial strains that promote
metabolism, binding or detoxification of DON (Kollarczik et al.,
1994; Young et al., 2007). By contrast, our results showed that
VFA concentrations were lowered in DON treated animals. ThisTable 6
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and their combination the inte
Item 0 FOS
0 CSE 15 mg/kg BW CSE
Medium jejunum 5.47 ± 0.26a 7.36 ± 0.55b
Ileum 5.19 ± 0.34a 6.26 ± 0.27b
FOS  CSE ¼ combination of FOS and CSE.
a, b Within a row, mean values with different superscripts differ significantly (P < 0.05).outcome at caecum level, where the mycotoxin would be metab-
olized by microorganisms, could be explained by a detrimental
effect of DON on the metabolism of culture independent bacterial
populations (Wache et al., 2009; Piotrowska et al., 2014).
C. scolymus extract treated animals showed a decrease in
Enterobacteriaceae and E:L ratio in caecum and colon. It has been
recently demonstrated by our research group that using CSE as feed
additive substantially increased bile production in pigs (Martínez
et al., 2018). Important bile effects on the intestinal microbiota
have been described involving 2 main mechanisms: a direct
detergent action on bacterial cell membranes (mainly in proximal
intestine) and an indirect action by interacting with specific nuclear
receptors (FXR, TGR 5, mainly in large intestine) and thus inducing
antimicrobial peptides synthesis (Inagaki et al., 2006; D'Aldebert
et al., 2009; Burrin et al., 2013; Nie et al., 2015). Furthermore,
Cremers et al. (2014) indicated that bile acid salts have profound
effects on many key proteins in bacteria. Results from different
studies suggest that bile salts could potentially induce DNA damage
through oxidative stress in E. coli (Bernstein et al., 1999a, 199b; Oh
et al., 2000). Therefore, bile acids are thought to have destructive
effects on gut microbes except for some bile acid tolerant bacteria.
Lactic acid bacteria can tolerate biliary acids by expressing bile salts
hydrolases (Begley et al., 2005), active efflux of bile acids/salts and
changes in composition and architecture of cell membrane and cell
wall (Ruiz et al., 2013; Nie et al., 2015). Thus, higher bile acids
concentration in gastrointestinal tract of CSE treated animals in our
study might have contributed to lower Enterobacteriaceae without
altering LAB. Moreover, the use of CSE as an additive of the piglets'
diet increased the concentration of butyrate, an important ener-
getic VFA in large intestine (Steer et al., 2000; Blottiere et al., 2003;
Bederska-Lojewska and Pieszka, 2011; Samanta et al., 2013). This
finding is consistent with other scientific studies that detected an
increase in the proportion of butyrate and an equal or lower con-
centration of acetate when diets containing other natural extracts
are consumed (Kleessen et al., 2001; Poulsen et al., 2002; Gibson
et al., 2004; Loh et al., 2006). Even if all VFA concentrations were
higher in CSE treated animals than in CSE free animals, statistically
significant differences were only observed for butyrate. This could
be attributed to the fact that butyrate producing bacteria are able to
use other VFA as a substrate. As an example, acetate constitutes a
type of substrate for cross-feeding interactions that occur among
colonic bacteria (Duncan et al., 2004; Mølbak et al., 2007; Patterson
et al., 2010; Liu et al., 2012a).
Fosfomycin treatments reduced Enterobacteriaceae in caecum
and colon exerting a bactericide effect, related to its low oral
bioavailability (Perez et al., 2012). Lactic acid bacteria populations,
capable of resisting relatively high bactericide antibiotic concen-
trations through different adaptive mechanisms (Bernier and
Surette, 2013; Munita et al., 2016), were not affected by FOS.
Further, a reduction in pH was observed in caecum and colon that
can be explained as a consequence of the diminished E:L ratio in
FOS treated animals. On the other hand, the observed significant
increase in caecal VFA concentrations could be indicating that the
development of FOS resistant bacteria (other than LAB) has not
been affected by the antibiotic (Frimondt-Møller, 2010; Clausenstinal absorptive area (IAA, mm2; n ¼ 6).
30 mg/kg BW FOS P-value
0 CSE 15 mg/kg BW CSE FOS  CSE
8.44 ± 0.88b 6.98 ± 0.44ab 0.0065
5.13 ± 0.31a 4.95 ± 0.33ab 0.0205
Table 7
Effect of fosfomycin (FOS), Cynara scolymus extract (CSE) and deoxynivalenol (DON) on goblet cells/100 villi and goblet cells/100 crypts in the small intestine of weaned piglets
(n ¼ 12).
Item FOS, mg/kg BW P-value CSE, mg/kg BW P-value DON, mg/kg BW P-value
0 30 0 15 0 50
Medium jejunum
Villi 882.42 ± 105.74 1,153.33 ± 120.80 0.0802 924.08 ± 130.74 1,111.67 ± 102.07 0.2165 1,175.75 ± 112.63 860.00 ± 109.05 0.0441
Crypts 1,053.75 ± 71.57 1,291.67 ± 86.14 0.0249 1,035.83 ± 73.56 1,309.58 ± 79.36 0.0116 1,192.50 ± 98.27 1,152.92 ± 73.40 0.6859
Ileum
Villi 1,080.83 ± 76.02 954.58 ± 75.52 0.1717 968.75 ± 86.17 1,066.67 ± 65.91 0.2847 1,162.92 ± 67.44 872.50 ± 61.84 0.0039
Crypts 1,287.58 ± 88.99 1,677.08 ± 81.43 0.0013 1,375.92 ± 122.47 1,588.75 ± 66.24 0.0499 1,487.17 ± 90.16 1,477.50 ± 115.38 0.9244
Table 8
Effect of fosfomycin (FOS) Cynara scolymus extract (CSE) and their combination on the percentages (%) of adherence of bacteria to intestinal mucus of weaned piglets (n ¼ 6).
Item 0 FOS 30 mg/kg BW FOS P-value
0 CSE 15 mg/kg BW CSE 0 CSE 15 mg/kg BW CSE FOS  CSE
Bacterial adhesion to the ileum mucus adhered 44.57 ± 5.09a 73.14 ± 7.53b 83.67 ± 4.02b 81.61 ± 6.08b 0.0049
FOS  CSE ¼ combination of FOS and CSE.
a, b Within a row, mean values without a common superscript letter differ significantly (P < 0.05).
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of intestinal health in weaned piglets.
When FOS and CSE were combined in the piglets' diet, the
reduction of Enterobacteriaceae in colon was similar to the effect
obtained when the treatments were administered individually,
though it was less pronounced at caecum level. This could be
explained by a possible interference of their mechanisms of action:
as a consequence of CSE consumption, bile acids concentrations
increase at intestine level (Martínez et al., 2018) and this would
trigger antimicrobial peptides synthesis (induced by biliary acids
through nuclear receptors). The modes by which antimicrobial in-
testinal peptides kill bacteria are varied: the cytoplasmic mem-
brane is a frequent target, but theymay also interferewith DNA and
protein synthesis, protein folding and cell wall synthesis (Jenssen
et al., 2006; Bahar and Ren, 2013; Mahlapuu et al., 2016). On the
other hand, FOS is transported into bacteria via both glycerol-3-
phosphate and hexose phosphate membrane transporter systems
and it interferes with the cytoplasmic step of bacterial cell wall
biosynthesis, the formation of the peptidoglycan precursor UDP-N-
acetylmuramic acid (Kahan et al., 1974; Gobernado, 2003;
Casta~neda-García et al., 2009; Popovic et al., 2010; Perez et al.,
2014). Interference between FOS and intestinal peptides' mecha-
nisms of action, at cytoplasmic or membrane transporter level,
could occur. Moreover, some cytoplasmic peptides show bacterio-
static effects that could antagonize bactericidal effect of FOS that
requires bacteria to grow at log phase to exert its action; i.e.
antagonistic effects may be due to inhibition of bacterial growth by
static agents (Nguyen et al., 2011).
4.2. Intestinal morpho-physiology
Clinical symptoms characteristic of DON intoxication were not
observed in the animals under study. The mycotoxin DON admin-
istered at 1 mg/kg of feed (50 mg/kg BW) in our experiment did not
affect IAA, which is in agreement with studies that indicate that
higher DON concentrations are needed to deteriorate the tissue at
this level (Grenier and Applegate, 2013). However, in the present
study, treatments with DON adversely affected the number of
goblet cells. Similarly, Obremski et al. (2008) obtained a lower
goblet cells count in jejunum of piglets maintained on diets
contaminated with DON for 14 d. In addition, Bracarense et al.
(2012) and Gerez et al. (2015) also reported lower goblet cell
counts in jejunum after administration of 1.5 to 3 mg/kg DONrespectively in the diet of animals during 4 to 5 wk. Apart from a
lower goblet cells count, a lower expression of mucins by these cells
would be expected after the ingestion of low DON concentrations
(Laparra and Sanz, 2009; Pinton et al., 2015; Robert et al., 2017). In
our study, this effect was reflected by a lower adherence of E. coli to
mucus. In addition, disaccharidase activity decreased with DON
treatments in the different portions of the intestine. The undesir-
able effect of the mycotoxin could be a consequence of its mecha-
nism of action as a potent inhibitor of protein synthesis, including
the synthesis of disaccharidases (Pestka, 2007; Xiao et al., 2015).
After FOS treatments, IAA and goblet cells were considerably
increased. In a previous study, Perez Gaudio et al. (2016) demon-
strated a protective effect of the antibiotic FOS on in vitro cell cul-
tures that would favor a trophic effect on intestinal mucosa. On the
other hand, certain antibiotics modulate physiological inflamma-
tion decreasing the catabolic cost of maintaining immune response,
thereby favoring mucosal anabolic processes (Niewold 2007, 2013;
Costa et al., 2011; Brown et al. 2016, 2017). A greater pathogenic
bacteria adhesion, obtained in the present work, can be explained
by an improved mucus production given by a greater goblet cells
count. Maltase activity was also increased in FOS treated groups,
being the most active disaccharidase, as expected for the age and
diet of the animals (Collington et al., 1990).
C. scolymus extract used as an additive in the diet significantly
increased IAA and goblet cells. These findings are consistent with
previous works which reported that using different sources of
natural extracts increased villi height and villi:crypts ratio in the
small intestine of weaned piglets (Touchette et al., 2002; Liu et al.,
2008; Liu et al., 2012; Yuan et al., 2017). In pigs, the action of bile
acids on the G proteinecoupled bile acid receptor (TGR5) found in
enteroendocrine cells stimulates secretion of glucagon like pep-
tides (GLP)-1 and 2, which function respectively as the major
incretin hormone involved in glucose homeostasis and key trophic
hormone in intestinal adaptation and growth in response to food
ingestion. In fact, the induction of GLP-2 secretion, by TGR5, is
involved in the trophic action of bile acids in the intestinal lumen
(le Roux et al., 2010; Jain et al., 2012). The observed increase in IAA
and goblet cells in our study could be explained by the direct tro-
phic effect given by an increased bile production (Burrin et al.,
2013; de Diego-Cabero et al., 2015). As stated before, the
increased bacterial adherence to mucus would be a direct conse-
quence of the increased number of goblet cells rendering a better
mucus quality. Maltase activity, which plays an important role at
G. Martínez et al. / Animal Nutrition 5 (2019) 386e395 393weaning, was increased in CSE treated groups at ileum level. This
could be related to the trophic effect of bile acids, augmented after
CSE administration, in this portion of the intestine through inter-
action with specific nuclear receptors (Inagaki et al., 2006; Chiang,
2009; Stojancevic et al., 2012; Burrin et al., 2013).
Beneficial effects observed after co-administration of FOS and
CSE on IAA and bacterial adherence to mucus did not exceed the
benefits of individual treatments. It could be possible that anti-
inflammatory mechanisms exerted by FOS and biliary acids, that
involve cytokines produced by intestine immune cells, interfere at
different levels (Tullio et al., 2008; Shen et al., 2009; Buret, 2010;
Yokota et al., 2010; Michalopoulos et al., 2011; Zhang et al., 2014;
Brown et al., 2017).5. Conclusions
In the present study, we have demonstrated the impact of FOS,
CSE and DON on intestinal health parameters.
Deoxynivalenol showed a deleterious effect at different levels of
the intestinal epithelium at sub-toxic concentrations. Thereby, the
presence of low levels of this mycotoxin in feed should not be
underestimated.
Fosfomycin and CSE improved all studied parameters in relation
to intestinal health. Particularly, CSE could be considered as a
nutritional strategy to prevent enteric disorders and improve in-
testinal health in post-weaned piglets, emerging as a possible
alternative to preventive use of antibiotics.
The knowledge of the intestinal effects of the studied com-
pounds contributes to understand the physiological/physio-
pathological gut changes and their potential productive
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